Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bbnx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Beta Bionics, Inc. (BBNX) measures how much investors pay for each dollar of the company's trailing earnings. BBNX's current PE ratio of N/A is calculated by dividing its stock price of $13.82 by its TTM earnings per share of -$1.50.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Equipment & Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Beta Bionics, Inc.You BBNX | $616M | N/A | — | -$1.50 |
 AdaptHealth Corp. AHCO | $1.3B | N/A | — | -$0.52 |
 Dynavax Technologies Corporation DVAX | $1.8B | 60.81x | — | $0.21 |
 Immatics N.V. IMTX | $1.2B | N/A | — | -$1.61 |
 Kestra Medical Technologies, Ltd. KMTS | $1.2B | N/A | — | -$2.30 |
 ORIC Pharmaceuticals, Inc. ORIC | $781M | N/A | — | -$1.47 |
 Precigen, Inc. PGEN | $1.1B | N/A | — | -$0.82 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.81 | — | |
2024-12-31 FY2024 | — | $-8.60 | — | |
2023-12-31 FY2023 | — | $-8.31 | — | |
2022-12-31 FY2022 | — | $-12.96 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Beta Bionics, Inc. (BBNX) measures how much investors pay for each dollar of the company's trailing earnings. BBNX's current PE ratio of N/A is calculated by dividing its stock price of $13.82 by its TTM earnings per share of -$1.50.
Frequently asked questions
BBNX pe ratio · 6 questionsBBNX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $13.82 and TTM EPS of -$1.50. Data sourced from Financial Modeling Prep via BBNX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Beta Bionics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08